Form 8-K - Current report:
SEC Accession No. 0001193125-26-168395
Filing Date
2026-04-22
Accepted
2026-04-22 07:40:17
Documents
17
Period of Report
2026-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d139552d8k.htm   iXBRL 8-K 46524
2 EX-4.1 d139552dex41.htm EX-4.1 368684
3 EX-10.1 d139552dex101.htm EX-10.1 70592
4 EX-10.2 d139552dex102.htm EX-10.2 9836
5 EX-10.3 d139552dex103.htm EX-10.3 18947
6 EX-10.4 d139552dex104.htm EX-10.4 19648
7 EX-99.1 d139552dex991.htm EX-99.1 11674
  Complete submission text file 0001193125-26-168395.txt   792860

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA hura-20260421.xsd EX-101.SCH 3184
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hura-20260421_lab.xml EX-101.LAB 17993
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hura-20260421_pre.xml EX-101.PRE 11264
21 EXTRACTED XBRL INSTANCE DOCUMENT d139552d8k_htm.xml XML 3719
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 26881299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)